CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
The aim of this study is to assess the level of glycemic control and the incidence of surgery-related complications in cardiac patients post...
Seoul, Korea, Republic of
This study will evaluate the clinical efficacy and safety of udenafil, an orally administered, potent and selective inhibitor of PDE5, versus placebo...
Phase 3
Seoul, Korea, Republic of and 30 other locations
Multi-center, prospective, randomized controlled study comparing PCI guided by angiography versus iFR Co-Registration using commercially available Ph...
Seoul, Korea, Republic of and 82 other locations
with placebo in reducing the risk of the clinical consequences of AKI (MAKE) at 90 days in adult participants with CKD who undergo non-emergent cardiac...
Phase 3
Seoul, Korea, Republic of and 195 other locations
The purpose of this study is to compare and assess efficacy and safety between the study device "TS-RF system consisting of a electrosurgical system,...
Bucheon, Korea, Republic of
The purpose of the study is to evaluate the safety and effectiveness of the PULSTA Transcatheter Pulmonary Valve (TPV) System for the treatment of co...
Seoul, Haehak-ro Jongno-gu, Korea, Republic of and 10 other locations
the safety and efficacy of drug-coated balloon (DCB) treatment compared to drug-eluting stenting (DES) in patients with large coronary artery disease...
Seoul, Korea, Republic of and 18 other locations
software to assist clinicians in the diagnosis of coronary artery disease by predicting coronary artery stenosis (≥50%) from a multimodal AI...
Seoul, Korea, Republic of and 4 other locations
This study will assess the effect of lowering low-density lipoprotein cholesterol (LDL-C) with evolocumab on major cardiovascular events in adults wi...
Phase 3
Seoul, Korea, Republic of and 851 other locations
cardiovascular events (MACE) including coronary heart disease (CHD) death, ischemic stroke, myocardial infarction (MI), acute limb...
Phase 3
Seoul, Korea, Republic of and 639 other locations
Clinical trials
Research sites
Resources
Legal